Time Frame for Admission of the First Russian HPV Vaccine to Medical Institutions
5 Articles
5 Articles
The country's health institutions will receive a start-up shipment of an innovative domestic drug called "Zegardeks" to prevent cancers by the end of this month, have reported to the Industrial Development Fund (IDF). 30,000 doses of the new drug are expected to be shipped at the end of September, RIA News is being transferred to RIA News. "Nanolek has put on the market the first Russian vaccine against the human papilloma virus "Zegardex", stre…
The national vaccine against the human papilloma virus (HPV) "Zegardex" of Nanolek's production has been released into civilian circulation; the first shipment of 30,000 doses will be delivered to medical institutions in late September, reported by the Director General of Nanolek Evgeny Barinov. "The original series of 30,000 doses has already been released, 600,000 doses will be produced before the end of the year", said Barinov at a press conf…
The first batch of a domestic vaccine against the human papilloma virus, Cegardex, will go to Russian medical institutions before the end of September, with 30,000 doses reported by Nanolek.
The Russian company Nanolek submitted a registration file for the first Russian quadvalent vaccine against the human papilloma virus (PHR) in Belarus, Kazakhstan, Armenia and Kyrgyzstan, which is scheduled to be obtained from the end of 2026 to the first quarter of 2027, reported to the company, wrote TASS, states that the vaccine protects against four types of HPV, 6, 11, 16 and [...].
The first batch of the Russian vaccine against the human papilloma virus (PHR) will go to medical institutions at the end of September, and have told RIA News at the Foundation... 22.09.2026, PRIM
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
